News

Novo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate ... representative in the GLP-1 agonist market to testify at the hearing.
Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of leadership was required amid fierce glucagon-like peptide 1 receptor ...
The CEO of Novo Nordisk plans to blame drug middlemen ... of the diabetes and weight loss drugs in April. Jorgensen agreed in June to testify, after Sanders had threatened him with a subpoena.
Sept. 24 (UPI) --The CEO of Novo Nordisk is on Capitol Hill Tuesday to testify before a Senate committee about the high costs of its drugs Ozempic and Wegovy. Chairman Sen. Bernie Sanders ...
Kaia Hubbard is a politics reporter for CBS News Digital, based in Washington, D.C. Novo Nordisk CEO Lars Fruergaard Jørgensen ... the three leading PBMs had agreed to not reduce access to ...
Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish drugmaker on Friday abruptly announced that longtime CEO Lars Fruergaard ...
Jørgensen has agreed to serve as the company’s CEO on an interim basis until his replacement is found. The Danish pharma giant added that Lars Rebien Sørensen, chair of the Novo Nordisk ...
The Danish drugmaker on Friday abruptly announced that longtime CEO Lars ... of several of Novo Nordisk's other recent tie-ups. For example, Novo Nordisk in March said it had agreed to pay up ...